ReviewAsian journal of andrology2026
Phytochemical-based nanomedicine as a promising therapeutic strategy for erectile dysfunction.
Review in Asian journal of andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erectile dysfunction (ED) is a common condition among aging men, often associated with metabolic disorders, diabetes mellitus, hypertension, oligozoospermia, cardiovascular disease, sedentary lifestyles, chronic infections, and inflammation. A major therapeutic challenge is the inefficient delivery of drugs to penile smooth muscle tissue. Moreover, synthetic pharmacological treatments frequently cause adverse effects, including off-target interactions and risks to vital organs, especially the heart. As a result, there is growing interest in phytochemicals derived from medicinal plants, which offer natural, cost-effective, and less toxic alternatives. Numerous preclinical and clinical studies have shown that phytochemicals support muscle function through antioxidant and anti-inflammatory properties, modulation of the phosphodiesterase type 5 (PDE5) pathway, and hormone regulation. This review highlights the potential of combining phytochemicals with nanotechnology to develop safer and more effective treatments for penile tissue disorders. We also examine nanomedicine delivery systems such as liposomes, nanoemulsions, and dendrimers that enhance the bioavailability, targeted delivery, and controlled release of these compounds. Overall, this review underscores the promise of phytochemical-based nanomedicine in improving therapies for penile smooth muscle dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.